Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract

Nutrition Research

Volumn 31, Issue 6, 2011, Pages 421-428

  Kubota, Kazumitsu ^a   Sumi, Shunichiro ^a   Tojo, Hideaki ^a   Sumi Inoue, Yukiko ^a   I chin, Hou ^b   Oi, Yasuyuki ^b   Fujita, Hiroyuki ^b   Urata, Hidenori ^a  

^a Fukuoka University Chikushi Hospital   (Japan)

^b Nippon Supplement Inc   (Japan)

Author keywords

Black Chinese tea; Food for Specified Health Uses: Human; Metabolic syndrome; Obesity; Pu Erh; Visceral fat area

Indexed keywords

BLACK TEA EXTRACT; PLACEBO;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARLEY; BODY MASS; BODY WEIGHT; BODY WEIGHT DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG SAFETY; ERYTHROCYTE COUNT; FEMALE; FLATULENCE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; JAPANESE; LEUKOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; OBESITY; OVERNUTRITION; PATIENT COMPLIANCE; PREOBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RETCHING; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; WAIST CIRCUMFERENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CAMELLIA SINENSIS; CHOLESTEROL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OVERWEIGHT; PLANT EXTRACTS; TEA; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; WAIST CIRCUMFERENCE;

ANIMALIA; HORDEUM;

EID: 79960211019     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.05.004     Document Type: Article

References (33)

1. Field A.E., Coakley E.H., Must A., Spadano J.L., Diets W.H., Rimm E., et al. Impact of overweight on the risk of developing common chronic disease during 10-year period. Arch Intern Med 2001, 161:1581-1586.
2. National Task Force on the Prevention and Treatment of Obesity Over-weight, obesity and health risk. Arch Intern Med 2000, 160:898-904.
3. Kenchaiah S., Evans J.C., Levy D., Lew D., Wilson P.W., Benjamin E.J., et al. Obesity and the risk of heart failure. N Engl J Med 2002, 347:305-313.
4. Key T.J., Allen N.E., Spencer E.A., Travis R.C. The effect of diet on risk of cancer. Lancet 2002, 288:1723-1727.
5. Gary D.M., Barbara J.N., Cralen D., Richard F.L., Leon L., Stephen P.M. Intensive weight loss program improves physical function in older obese adults with knee osteoarthritis. Obesity 2006, 139:1219-1230.
6. World Health Organization Obesity: preventing and managing the global epidemic 1998, World Health Organization, Geneva.
7. Yoo H.J., Kim B.T., Park Y.W., Park K.H., Kim K.W., Joo N.S. Difference of body compositional changes according to the presence of weight cycling in a community-based weight control program. J Korean Med Sci 2010, 25:49-53.
8. Fujita H., Yokoyama K., Yoshikawa M. Classification and antihypertensive activity of angiotensin I-converting enzyme derived from food proteins. J Food Sci 2000, 65:564-569.
9. Fujita H., Yamagami T., Ohshima K. Long-term ingestion of a fermented soybean-derived touchi-extract with α-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. J Nutr 2001, 131:2105-2108.
10. Najm W., Lie D. Herbals used for diabetes, obesity, and metabolic syndrome. Prim Care 2010, 37:237-254.
11. Tsuji H., Kasai M., Takeuchi H., Nakamura M., Okazaki M., Kondo K. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double blind, controlled trial in healthy men and women. J Nutr 2001, 131:2853-2859.
12. Marie-pierre S.O., Aubrey B. Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than dose olive oil. J Clin Nutr 2008, 87:621-626.
13. Nagao T., Watanabe H., Goto N., Onizawa K., Taguchi H., Matsuo N., et al. Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double-blind control trial. J Nutr 2000, 130:792-797.
14. Michael B., Frank T. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr 2007, 26:389S-395S.
15. Sabu M.C., Priya T.T., Ramadasan K., Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med 2010, 5:13-22.
16. Hosokawa M., Miyashita T., Nishikawa S., Emi S., Tsukui T., Beppu F., et al. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch Biochem Biophys 2010, 504:17-25.
17. Tsuchida T., Itakura H., Nakamura H. Reduction of body fat in humans by long-term ingestion of catechins. Prog Med 2002, 22:2189-2203.
18. Ikeda I., Imasato Y., Sasaki E., Nakayama M. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochem Biophys Acta 1992, 1127:141-146.
19. Lin J.K., Lin C.L., Liang Y.C. Survey of catechins, gallic acid, and methylxanthines in green, oolong, Pu-Erh, and black teas. J Agric Food Chem 1998, 46:3635-3642.
20. Hsu C.L., Yen G.C. Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br J Nutr 2007, 98:727-735.
21. Fujita H., Yamagami T. Efficacy and safety of Chinese black tea (Pu-Erh) extract in healthy and hypercholesterolemic subjects. Ann Nutr Metab 2008, 53:33-42.
22. Fujita H., Yamagami T. Anti-hypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 2008, 28:450-456.
23. Fujita H., Yamagami T. Extract of black tea (Pu-Erh) inhibits postprandial rise in serum cholesterol in mice, and with long term use reduces serum cholesterol and low density lipoprotein levels and renal fat weight in rats. Phytother Res 2008, 22:1275-1281.
24. The Examination committee of criteria for "Obesity disease" in Japan. Japan society for the study of obesity. New criteria for "Obesity disease". Cric J 2002, 66:987-992.
25. Japan Diabetes Society Food-Calorie Conversion Table, 5th ed Bunkodo, Tokyo, Japan (in Japanese) 1993.
26. Yang T.T.C., Koo M.W.L. Hypocholesterolemic effect of Chinese tea. Pharma Res 1997, 35:505-512.
27. Kuo K.L., Weng M.S., Chiang C.T., Tsai Y.J., Linshiau S.Y., Lin J.K. Comparative studies of the hypolipidemic and growth suppressive effects of oolong, black, Pu-Erh, and green tea leaves in rats. J Agric Food Chem 2005, 53:480-489.
28. Toris T., Satoh Y., Fujita H., Nagaoka T., Kawabata J. The structure and activity of Yunnann fermented tea on mixed bile salt micelles. Nippon Nougeikagakukaisi 2007, (Suppl):261. (in Japanese).
29. Kobayashi M., Ikegami H., Fujisawa T., Nojima K., Kawabata Y., Noso S., et al. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes 2007, 56:239-247.
30. Way T.Z., Lin H.Y., Kuo D.H. Pu-Erh tea attenuates hyperlipogenesis and induces hepatoma cells growth arrest through activating AMP-activated protein kinase (AMPK) in Human HepG2 cells. J Agric Food Chem 2009, 57:5257-5264.
31. Lin Y.S., Tsai Y.J., Lin J.K. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem 2003, 51:1864-1873.
32. Lin J.K., Lin-Shiau S.Y. Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res 2006, 50:211-217.
33. Heckman M.A., Weil J., Gozalez M.E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 2010, 75:R77-R87.